Tsai CM - Search Results

1

First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study.

Soria JC, Tan DSW, Chiari R, Wu YL, Paz-Ares L, Wolf J, Geater SL, Orlov S, Cortinovis D, Yu CJ, Hochmair M, Cortot AB, Tsai CM, Moro-Sibilot D, Campelo RG, McCulloch T, Sen P, Dugan M, Pantano S, Branle F, Massacesi C, de Castro G Jr. Soria JC, et al. Among authors: tsai cm. Lancet. 2017 Mar 4;389(10072):917-929. doi: 10.1016/S0140-6736(17)30123-X. Epub 2017 Jan 24. Lancet. 2017. PMID: 28126333 Clinical Trial.

2

[Small cell lung cancer and long-term survival: our experience in VGH-Taipei from 1971 to 1985].

Chen YM, Tsai CM, Perng RP. Chen YM, et al. Among authors: tsai cm. Zhonghua Yi Xue Za Zhi (Taipei). 1992 Apr;49(4):271-6. Zhonghua Yi Xue Za Zhi (Taipei). 1992. PMID: 1318152 Chinese.

3

Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer.

Chen YM, Wu MF, Perng RP, Chou CM, Yang KY, Lin WC, Tsai CM, Liu JM, Whang-Peng J. Chen YM, et al. Among authors: tsai cm. Jpn J Clin Oncol. 1997 Apr;27(2):76-9. doi: 10.1093/jjco/27.2.76. Jpn J Clin Oncol. 1997. PMID: 9152794 Clinical Trial.

4

Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study.

Perng RP, Chen YM, Ming-Liu J, Tsai CM, Lin WC, Yang KY, Whang-Peng J. Perng RP, et al. Among authors: tsai cm. J Clin Oncol. 1997 May;15(5):2097-102. doi: 10.1200/JCO.1997.15.5.2097. J Clin Oncol. 1997. PMID: 9164223 Clinical Trial.

5

Ifosfamide-based chemotherapy for previously treated lung cancer patients.

Chen YM, Liu JM, Wu MF, Wu HW, Lin WC, Tsai CM, Perng RP, Whang-Peng J. Chen YM, et al. Among authors: tsai cm. Zhonghua Yi Xue Za Zhi (Taipei). 1998 Jul;61(7):389-96. Zhonghua Yi Xue Za Zhi (Taipei). 1998. PMID: 9699391 Clinical Trial.

6

Non-small cell lung cancer in very young and very old patients.

Kuo CW, Chen YM, Chao JY, Tsai CM, Perng RP. Kuo CW, et al. Among authors: tsai cm. Chest. 2000 Feb;117(2):354-7. doi: 10.1378/chest.117.2.354. Chest. 2000. PMID: 10669674

7

A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer.

Chen YM, Perng RP, Yang KY, Lin WC, Wu HW, Liu JM, Tsai CM, Whang-Peng J. Chen YM, et al. Among authors: tsai cm. Am J Clin Oncol. 2000 Feb;23(1):13-7. doi: 10.1097/00000421-200002000-00003. Am J Clin Oncol. 2000. PMID: 10683066 Clinical Trial.

8

A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non--small-cell lung cancer.

Perng RP, Shih JF, Chen YM, Delgado FM, Tsai CM, Chou KC, Liu JM, Chern MS, Whang-Peng J. Perng RP, et al. Among authors: tsai cm. Am J Clin Oncol. 2000 Feb;23(1):60-4. doi: 10.1097/00000421-200002000-00017. Am J Clin Oncol. 2000. PMID: 10683080 Clinical Trial.

9

A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (Stage IIIB/IV) non-small cell lung cancer.

Chen YM, Perng RP, Yang KY, Liu TW, Tsai CM, Ming-Liu J, Whang-Peng J. Chen YM, et al. Among authors: tsai cm. Chest. 2000 Jun;117(6):1583-9. doi: 10.1378/chest.117.6.1583. Chest. 2000. PMID: 10858387 Clinical Trial.

10

Treatment of non-small-cell lung cancer: the Chinese experience in a general teaching hospital.

Chen YM, Chao JY, Tsai CM, Shiau CY, Liang MJ, Yen SH, Perng RP. Chen YM, et al. Among authors: tsai cm. Zhonghua Yi Xue Za Zhi (Taipei). 2000 Jun;63(6):459-66. Zhonghua Yi Xue Za Zhi (Taipei). 2000. PMID: 10925536

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

444 results

Search Page